Concord Medical (NYSE: CCM) reviews status of Hong Kong affiliate after board changes

Rhea-AI Filing Summary

Concord Medical Services Holdings Limited filed a Form 6-K to update investors on governance changes at its Hong Kong–listed affiliate, Concord Healthcare Group Co., Ltd. The filing notes that Mr. Liang Chang resigned as an executive director of Concord Healthcare effective May 11, 2026, for personal career planning reasons, and that Ms. Li Jiang was elected as an employee director on the same day.

The company’s management is reviewing how these board changes affect whether Concord Healthcare continues to qualify as a consolidated subsidiary under applicable accounting standards. Concord Medical states it will provide further information once the review is completed or a material determination is made, and it cautions investors and shareholders to exercise care when dealing in its securities.

Insights

Cross-border accounting & governance analyst

Board changes at a key affiliate may affect consolidation status, but impact is still under review.

Concord Medical reports director changes at Hong Kong–listed Concord Healthcare and explicitly flags a review of whether that entity will remain a consolidated subsidiary under applicable accounting standards. Consolidation status influences how Concord Healthcare’s assets, liabilities, and results appear in Concord Medical’s financial statements.

The filing does not state any conclusion, only that management is assessing implications and will update the market upon a material determination. The cautionary language to investors suggests potential accounting or reporting changes, but timing and impact remain open until the review is complete.

Key Terms

consolidated subsidiary, forward-looking statements, executive director, employee director, +1 more

5 terms

consolidated subsidiary financial

"including whether Concord Healthcare continues to qualify as a consolidated subsidiary of the Company under applicable accounting standards."

forward-looking statements regulatory

"This report contains forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended."

Forward-looking statements are predictions or plans that companies share about what they expect to happen in the future, like estimating sales or profits. They matter because they help investors understand a company's outlook, but since they are based on guesses and assumptions, they can sometimes be wrong.

executive director financial

"Mr. Liang Chang resigned from his position as an executive director of Concord Healthcare effective May 11, 2026"

An executive director is a senior leader who both sits on a company’s board and runs day-to-day operations or a major business unit, acting like the bridge between oversight and execution. Investors watch this role because the person sets strategy, makes key resource and hiring decisions, and is accountable for performance—similar to a ship’s captain who also helps steer the fleet.

employee director financial

"Ms. Li Jiang was elected as an employee director of the board of directors of Concord Healthcare"

Report of Foreign Private Issuer regulatory

"FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16"

A report of a foreign private issuer is a formal filing that a non‑U.S. company makes to U.S. regulators to share important business, financial, or governance information with American investors. Think of it as a regular update or press packet that keeps investors informed about events that could change a company’s value—like earnings, management changes, contracts, or regulatory developments—so investors can make timely, informed decisions.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 6-K: How Foreign Companies Report to the SEC →

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16 UNDER

THE SECURITIES EXCHANGE ACT OF 1934

For the month of May 2026

Commission File Number: 001-34563

CONCORD MEDICAL SERVICES HOLDINGS LIMITED

Room A1-A5 26/F, East Zone, Hanwei Plaza

No. 7 Guanghua Road, Chaoyang District,

Beijing 100020

People’s Republic of China

(Address of principal executive office)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F    x         Form 40-F   ¨

EXPLANATORY NOTE

This Report on Form 6-K is being filed by Concord Medical Services Holdings Limited (the "Company") (NYSE: CCM) to provide an update regarding the previously announced changes to the board of directors of Concord Healthcare Group Co., Ltd. ("Concord Healthcare"), a company listed on the Main Board of The Stock Exchange of Hong Kong Limited (the "HKSE") under the stock code 2453.HK.

SUBSEQUENT DEVELOPMENTS REGARDING CHANGE OF EXECUTIVE DIRECTOR

As previously disclosed, Mr. Liang Chang resigned from his position as an executive director of Concord Healthcare effective May 11, 2026, due to personal career planning considerations. In addition, Ms. Li Jiang was elected as an employee director of the board of directors of Concord Healthcare at the employee representatives' meeting held on the same day.

The Company's management is reviewing the implications of the changes to the board composition of Concord Healthcare, including whether Concord Healthcare continues to qualify as a consolidated subsidiary of the Company under applicable accounting standards.

The Company will provide further information when this review is completed or if it makes any material determination. There can be no assurance as to the timing or outcome of the review. Investors and shareholders are advised to exercise caution when dealing in the Company's securities.

FORWARD-LOOKING STATEMENTS

This report contains forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended. These statements involve known and unknown risks, uncertainties, and other factors that may cause the Company's actual results, performance, or achievements to be materially different from those expressed or implied by the forward-looking statements. The Company undertakes no obligation to update or revise any forward-looking statements, whether because of new information, future events, or otherwise.

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

CONCORD MEDICAL SERVICES HOLDINGS LIMITED

	By:	/s/ Jianyu Yang
	Name:	Jianyu Yang
	Title:	Chairman and Chief Executive Officer

Date: May 18, 2026

FAQ

What does Concord Medical (CCM) disclose in this Form 6-K?

Concord Medical reports board changes at its Hong Kong–listed affiliate, Concord Healthcare. It notes a director resignation, a new employee director appointment, and an ongoing review of whether Concord Healthcare will continue to be treated as a consolidated subsidiary for accounting purposes.

Which board changes at Concord Healthcare are highlighted by Concord Medical (CCM)?

The company states that Mr. Liang Chang resigned as an executive director of Concord Healthcare effective May 11, 2026. On the same day, Ms. Li Jiang was elected as an employee director at an employee representatives’ meeting, altering the board’s composition.

Why is Concord Medical (CCM) reviewing Concord Healthcare’s consolidation status?

Management is examining how recent board composition changes at Concord Healthcare affect whether it still qualifies as a consolidated subsidiary under accounting standards. This status determines if Concord Healthcare’s financials are fully included in Concord Medical’s consolidated statements.

Has Concord Medical (CCM) decided if Concord Healthcare remains a consolidated subsidiary?

No decision is reported yet. Concord Medical explains that its review of Concord Healthcare’s consolidation status is ongoing and promises to provide more information once the review is completed or if it makes any material determination on the matter.

What caution does Concord Medical (CCM) give investors in this update?

The company advises investors and shareholders to exercise caution when dealing in its securities. This warning is tied to uncertainty around the outcome and timing of its review of Concord Healthcare’s consolidation status following the board changes.

Does the Concord Medical (CCM) Form 6-K contain forward-looking statements?

Yes. The report includes a forward-looking statements section referencing risks, uncertainties, and other factors that may cause actual results to differ from expectations, and notes the company has no obligation to update those statements as circumstances change.